Riluzole for Patients Undergoing Decompressive Surgery for Degenerative Cervical Myelopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Riluzole in Patients Undergoing Decompressive Surgery for Degenerative Cervical Myelopathy (CSM-Protect): A Multicentre, Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial
Lancet Neurol 2021 Feb 01;20(2)98-106, MG Fehlings, JH Badhiwala, H Ahn, HF Farhadi, CI Shaffrey, A Nassr, P Mummaneni, PM Arnold, WB Jacobs, KD Riew, M Kelly, DS Brodke, AR Vaccaro, AS Hilibrand, J Wilson, JS Harrop, ST Yoon, KD Kim, DR Fourney, C Santaguida, EM Massicotte, B KopjarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.